See more : Smith-Midland Corporation (SMID) Income Statement Analysis – Financial Results
Complete financial analysis of SCP & CO Healthcare Acquisition Company (SHACU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SCP & CO Healthcare Acquisition Company, a leading company in the Shell Companies industry within the Financial Services sector.
- LIAONING ENERGY INDUSTRY Co.,LTD (600758.SS) Income Statement Analysis – Financial Results
- United Overseas Bank Limited (U11.SI) Income Statement Analysis – Financial Results
- Amir Marketing and Investments in Agriculture Ltd (AMRK.TA) Income Statement Analysis – Financial Results
- Silver Dollar Resources Inc. (SLVDF) Income Statement Analysis – Financial Results
- Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS) Income Statement Analysis – Financial Results
SCP & CO Healthcare Acquisition Company (SHACU)
About SCP & CO Healthcare Acquisition Company
SCP & CO Healthcare Acquisition Company does not have significant business. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to identify a prospective target business in the healthcare technology or healthcare-related platform in the United States and other developed countries. The company was incorporated in 2020 and is based in Tampa, Florida.
| Metric | 2021 | 2020 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 1.41M | 0.00 |
| Gross Profit | -1.41M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 |
| Other Expenses | 1.41M | 0.00 |
| Operating Expenses | 1.41M | 0.00 |
| Cost & Expenses | 1.41M | 0.00 |
| Interest Income | 106.29K | 0.00 |
| Interest Expense | 106.29K | 0.00 |
| Depreciation & Amortization | 10.28M | 206.30K |
| EBITDA | 8.87M | 0.00 |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -1.41M | 0.00 |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 10.17M | 0.00 |
| Income Before Tax | 8.76M | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | -10.28M | 0.00 |
| Net Income | 19.04M | 0.00 |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 0.70 | 0.00 |
| EPS Diluted | 0.70 | 0.00 |
| Weighted Avg Shares Out | 27.12M | 28.75M |
| Weighted Avg Shares Out (Dil) | 27.12M | 28.75M |
SCP & CO Healthcare Acquisition Company Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 15, 2021
U.S. IPO Weekly Recap: The IPO Market Has No Time To RLX In A 6-IPO Week
Source: https://incomestatements.info
Category: Stock Reports